Scientific Literature Search

Source record

Curcumin modulates α-synuclein aggregation and toxicity.

Singh PK, Kotia V, Ghosh D, Mohite GM, Kumar A, Maji SK.

ACS Chem Neurosci · 2012-12-17

DOI: 10.1021/cn3001203PMID: 23509976

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Development of an enzyme-linked immunosorbent assay for detection of cellular and in vivo LRRK2 S935 phosphorylation.

Delbroek L, Van Kolen K, Steegmans L, da Cunha R, Mandemakers W, Daneels G, De Bock PJ, Zhang J, Gevaert K, De Strooper B, Alessi DR, Verstreken P, Moechars DW.

J Pharm Biomed Anal · 2012-12-16

DOI: 10.1016/j.jpba.2012.12.002PMID: 23313773

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Detection of α-synuclein amyloidogenic aggregates in vitro and in cells using light-switching dipyridophenazine ruthenium(II) complexes.

Cook NP, Kilpatrick K, Segatori L, Martí AA.

J Am Chem Soc · 2012-12-14

DOI: 10.1021/ja3100287PMID: 23237404

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Covalent α-synuclein dimers: chemico-physical and aggregation properties.

Pivato M, De Franceschi G, Tosatto L, Frare E, Kumar D, Aioanei D, Brucale M, Tessari I, Bisaglia M, Samori B, de Laureto PP, Bubacco L.

PLoS One · 2012-12-13

DOI: 10.1371/journal.pone.0050027PMID: 23272053

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2.

Biosa A, Trancikova A, Civiero L, Glauser L, Bubacco L, Greggio E, Moore DJ.

Hum Mol Genet · 2012-12-13

DOI: 10.1093/hmg/dds522PMID: 23241358

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetics of impulse control disorders in Parkinson's disease.

Cormier F, Muellner J, Corvol JC.

J Neural Transm (Vienna) · 2012-12-12

DOI: 10.1007/s00702-012-0934-4PMID: 23232665

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central China.

Wang Y, Liu L, Xiong J, Zhang X, Chen Z, Yu L, Chen C, Huang J, Zhang Z, Mohmed AA, Lin Z, Xiong N, Wang T.

Behav Brain Funct · 2012-12-10

DOI: 10.1186/1744-9081-8-57PMID: 23227814

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons.

Cherra SJ, Steer E, Gusdon AM, Kiselyov K, Chu CT.

Am J Pathol · 2012-12-08

DOI: 10.1016/j.ajpath.2012.10.027PMID: 23231918

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Dominant-negative effects of LRRK2 heterodimers: a possible mechanism of neurodegeneration in Parkinson's disease caused by LRRK2 I2020T mutation.

Ohta E, Kawakami F, Kubo M, Obata F.

Biochem Biophys Res Commun · 2012-12-07

DOI: 10.1016/j.bbrc.2012.11.113PMID: 23220480

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

α-Synuclein oligomers and clinical implications for Parkinson disease.

Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE.

Ann Neurol · 2012-12-07

DOI: 10.1002/ana.23746PMID: 23225525

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.

Holmans P, Moskvina V, Jones L, Sharma M, International Parkinson's Disease Genomics Consortium, Vedernikov A, Buchel F, Saad M, Bras JM, Bettella F, Nicolaou N, Simón-Sánchez J, Mittag F, Gibbs JR, Schulte C, Durr A, Guerreiro R, Hernandez D, Brice A, Stefánsson H, Majamaa K, Gasser T, Heutink P, Wood NW, Martinez M, Singleton AB, Nalls MA, Hardy J, Morris HR, Williams NM.

Hum Mol Genet · 2012-12-07

DOI: 10.1093/hmg/dds492PMID: 23223016

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetics and iron in the systems biology of Parkinson's disease and some related disorders.

Funke C, Schneider SA, Berg D, Kell DB.

Neurochem Int · 2012-12-07

DOI: 10.1016/j.neuint.2012.11.015PMID: 23220386

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

15.286 articles found

Curcumin modulates α-synuclein aggregation and toxicity.

Development of an enzyme-linked immunosorbent assay for detection of cellular and in vivo LRRK2 S935 phosphorylation.

Detection of α-synuclein amyloidogenic aggregates in vitro and in cells using light-switching dipyridophenazine ruthenium(II) complexes.

Covalent α-synuclein dimers: chemico-physical and aggregation properties.

GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2.

Genetics of impulse control disorders in Parkinson's disease.

Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central China.

Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons.

Dominant-negative effects of LRRK2 heterodimers: a possible mechanism of neurodegeneration in Parkinson's disease caused by LRRK2 I2020T mutation.

α-Synuclein oligomers and clinical implications for Parkinson disease.

A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.

Genetics and iron in the systems biology of Parkinson's disease and some related disorders.

Filters